VERA - Company ID 0001831828
The table below shows Vera Therapeutics, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $354.73M | $92.65M | $45.68M | $43.46M | $79.67M |
| Short-term investments | $359.86M | $548.21M | $115.03M | $71.19M | - |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $728.88M | $651.22M | $172.02M | $125.70M | $82.54M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $1.37M | $960.00K | $92.00K | $51.00K | - |
| Goodwill | - | - | - | - | - |
| Total assets | $734.73M | $655.68M | $175.55M | $131.44M | $83.75M |
| Accounts payable | $21.90M | $7.67M | $11.12M | $11.99M | $1.39M |
| Total current liabilities | $53.45M | $25.37M | $22.30M | $25.60M | $7.69M |
| Long-term debt | $74.84M | $50.69M | $49.88M | $24.81M | $4.92M |
| Total liabilities | $130.21M | $78.53M | $73.86M | $54.53M | $14.16M |
| Retained earnings | -$760.87M | -$461.25M | -$309.10M | -$213.11M | -$124.06M |
| Total equity | $604.52M | $577.15M | $101.69M | $76.91M | $69.59M |